We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 14.81% | 1.55 | 1.50 | 1.60 | 1.60 | 1.35 | 1.35 | 1,807,615 | 10:24:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.43 | 2.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2018 15:31 | Still expecting a Note from Hybridan at some point This is serious game-changing stuff I wonder also if given the change/acceleration in contract wins (Merck has obviously started a domino effect) whether we might get a Upwards Profit Warning RNS at some point soon ? Remember the October 2nd RNS said 'we expect contracts to be signed at least one of the three Pharmas we are in discussions with within six months' Six months would have been April 2nd So having 2 of the 3 in the bag by Feb 9th is looking like revenues are 'ahead of expectations as well as a magnitude above expectations' ? And what happens if the 3rd Pharma also signs up We are still also waiting on the Service Provider collaborations. Physiomics were in discussions with 6 and expected '1 to convert within sic months' Finally the mega biggee that could completely transform this stock is the B2C Personalised Medicine stuff. IF they crack that this goes Global and Stellar IMO Remember PYC told us there is interest from 'Government AND Investors' in providing 'SUBSTANTIAL NON-DILUTIVE' funding for that Cancer DSS tool. I can imagine because whilst you might roll it out in NHS for 'limited revenues' you could sell it for mega bucks to Private US Healthcare/Insurance providers | the stigologist | |
09/2/2018 15:14 | Let the run begin. Looking forward to seeing where the share price is come Tuesday close! | margic | |
09/2/2018 14:27 | Don't matter mate, that 240 chart looks likes it's going to lift off in the next few bar. Golden cross will confirm at 4pm with higher time frames all good to go! | margic | |
09/2/2018 14:24 | People who have real money don't behave in that kind of way as they have morals. Yes one could say he did nothing wrong but the fact is that he did this because he could and people were sucked in as they anticipated that here is a guy who is building up a stake in excess of 5% of this small company and who is interested in supporting this small cap co. But of course all he did was manipulate the speculation that surrounded the Physiomics story and trashed the share and a lot of small pis lost money. Ok so not illegal but in my book is behaviour was so wrong on a number of levels. Right back to Physiomics going forward I remain invested and looking forward to 30p again which is only a c/v of less than £20M GLAHS | billthebank | |
09/2/2018 14:14 | Nice, had a feeling volumes may pick up late. Going to hit 5-6mil imo | margic | |
09/2/2018 14:13 | Placing at 11p coming any day soon! | strongbuy | |
09/2/2018 13:13 | icejelly .. yep, didn't think of that. BTW you say he did nothing wrong and legally he didn't. What he did though was this, he conived to manipulate the TR1 reporting system, which is in place to keep the market informed, to deliberately disadvantage the market. I hope he's used his profits wisely, by beefing up his home security system, installing more cameras, employing 24/7 dog patrol, having a full time body guard and building a reinforced panic room..... just in case. | minja19 | |
09/2/2018 12:55 | JC could buy?! | icejelly | |
09/2/2018 12:53 | perfect ... what could possible go wrong | minja19 | |
09/2/2018 12:47 | I agree the more contracts or even partnerships and projects with the big boys it certainly does apply pressure as it can start to quickly run away from you. 240 chart golden cross happening now and will confirm before 4pm it seems. Should move to daily moving average today. I don't feel this Friday will end quietly at PYC today. Can see this building to close. | margic | |
09/2/2018 12:42 | The more Pharmas come on board greater the pressure on Certara. Certara and their PE/VC owners have a $1bn bet on this market. They will want/need to show FDA / Pharma customers / Investors that they truly are comprehensive Industry Standard platform but you can't without the Oncology component. Physiomics are far and away No.1 in Oncology now | the stigologist | |
09/2/2018 12:36 | This looks like it has a very big move in it. The right rns can bring some serious fruition. I can certainly sense there's a build up from the company here and something much larger is about to drop. This contract upgrade is double the previous one. They said they were talking to a few major pharmas and wanted to nail one. They've just hit 3. | margic | |
09/2/2018 11:10 | Something very big is coming... I sense They telegraphed the rise from 1p to 32p in the October 2nd 2017 RNS I expect an update or major RNS soon which will see us move from pitiful 7p to 50-100p | the stigologist | |
09/2/2018 11:10 | I agree re Jim Millen Professional and will transform this company.Embryonic bit £600k for this year alone not bad not bad at all for a sub £5M co. | billthebank | |
09/2/2018 11:01 | I hate Friday RNSes but it shows the quality of Dr Jim Millen He isn't over egging the pudding. Merck £0.5m contract announced on a Tuesday. Allowed Market to digest news over the week. These last two pilot trial type contracts are good starting points but they aren't the real big deals so quite rightly he announces them on a Friday which traditionally is slower day with many in City treating it as part of their weekend wind down That tells me he is confident these will convert or other even more significant news to come Having spoken to the guy I think he's going to transform this Company. He could run a £100m or £500m Company quite easily Quality guy. Read his Bio! Queens, Cambridge Doctor at Royal London Hospital MBA INSEAD Glaxo Allergan Tree Hill Partners | the stigologist | |
09/2/2018 10:51 | Jim Millen, CEO said: "We believe that the signing of agreements with three major pharmaceutical clients within the space of three months is a real sign of the confidence in our technology that is starting to build within the industry. Our aim now will be to develop longer-term relationships with these major companies and to secure further pre-clinical and clinical projects." | billthebank | |
09/2/2018 10:50 | The two latest contracts will be completed by our financial year end which is in a couple of months.Hopefully both of these tasters? will lead to much larger contracts.Great news for a small £5M company.Jim Millen is doing a cracking job in a very short space of time. | billthebank | |
09/2/2018 10:46 | 3rd contract in as many months. Any other aim shares that have done this and generated 600k worth of value???? Plesee let me know | spacedust | |
09/2/2018 10:46 | So if think it is jam tomorrow and you are selling/sold, why are you still here on this board? Get out while you can and move on? But really you think it is going to go up? | icejelly | |
09/2/2018 10:42 | Unfortunately it is jam tomorrow. Very small contracts are being delivered | volsung | |
09/2/2018 10:41 | Do you count this one PYC as jam tomorrow? I don't call it a jam tomorrow share, it IS delivering. | icejelly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions